Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Baiyunshan Hutchison Whampoa Chinese Medicine is a prominent Chinese pharmaceutical company specializing in the research, development, manufacture, and marketing of traditional Chinese medicine (TCM) and over-the-counter (OTC) products. Established in 2005 as a joint venture, the company's portfolio includes well-known TCM brands such as Banlangen granules, Compound Danshen tablets, Kouyanqing granules, and Xiaoyan Lidan tablets. The company is dedicated to the modernization, internationalization, and popularization of traditional Chinese medicine, utilizing advanced scientific research to validate and enhance classical formulations. It operates several GAP-compliant herb cultivation bases across China and collaborates with leading research institutions, including the State Key Laboratory of Respiratory Disease led by Dr. Zhong Nanshan.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广州白云山和记黄埔中药.